In the present study, we aimed at estimating the production of medical Ac-225 radionuclide via proton accelerator in the energy range Eproton=1000 ›1 MeV under certain conditions, on thorium target material instead of uranium due to the low abundant of uranium in nature. Hence, to produce the medical Ac-225, cross-section, separation energy was calculated by taking into account the proton induced reaction processes that were simulated to estimate activity and, yield of the product up to 1000 MeV. Moreover, the calculated integral yields of reactions were presented. For achieving the aim, we have put forward the X-PMSP program to derive mass stopping power from a new perspective. © 2017 Elsevier Lt
In the present paper, we mainly aim to extend nuclear data of production of radionuclide promethium-...
This thesis deals with the idea of using accelerator driven systems for thorium transmutation into t...
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons...
With recent impressive clinical results of targeted alpha therapy using 225Ac, significant effort ha...
The feasibility of producing Ac-225 by proton irradiation of Ra-226 in a cyclotron through the react...
During the purification of radioisotopes, decay periods or time dependent purification steps may be ...
The science of cancer research is currently expanding its use of alpha particle emitting radioisotop...
High energy proton spallation reactions on natural thorium metal targets have been utilized to produ...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
A procedure is described for the accelerator production of 232pa and its isolation in radio-chemical...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
230U and its daughter nuclide 226Th are novel therapeutic nuclides for application in targeted r-the...
We developed a new version of the X-PMSP program for estimating mass stopping powers in charged part...
[Aim] We evaluated the production feasibility of Ac-225 (T1/2 = 10 d, decay to Bi-209 via 4α+2β) by ...
In the United States, cancer is the second leading cause of death and a major public health problem ...
In the present paper, we mainly aim to extend nuclear data of production of radionuclide promethium-...
This thesis deals with the idea of using accelerator driven systems for thorium transmutation into t...
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons...
With recent impressive clinical results of targeted alpha therapy using 225Ac, significant effort ha...
The feasibility of producing Ac-225 by proton irradiation of Ra-226 in a cyclotron through the react...
During the purification of radioisotopes, decay periods or time dependent purification steps may be ...
The science of cancer research is currently expanding its use of alpha particle emitting radioisotop...
High energy proton spallation reactions on natural thorium metal targets have been utilized to produ...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
A procedure is described for the accelerator production of 232pa and its isolation in radio-chemical...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
230U and its daughter nuclide 226Th are novel therapeutic nuclides for application in targeted r-the...
We developed a new version of the X-PMSP program for estimating mass stopping powers in charged part...
[Aim] We evaluated the production feasibility of Ac-225 (T1/2 = 10 d, decay to Bi-209 via 4α+2β) by ...
In the United States, cancer is the second leading cause of death and a major public health problem ...
In the present paper, we mainly aim to extend nuclear data of production of radionuclide promethium-...
This thesis deals with the idea of using accelerator driven systems for thorium transmutation into t...
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons...